Renewable Thermal Collaborative Releases Case Study on the U.S. Renewable Natural Gas (RNG) Agreement between AstraZeneca and Vanguard RenewablesBusiness Wire • 03/04/24
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast CancerBusiness Wire • 03/04/24
SCRI Announces a Collaboration with AstraZeneca Focused on Technology Enhancements & Innovative Operational Model to Advance Cancer ResearchBusiness Wire • 02/28/24
Sodexo and AstraZeneca extend their global partnership for a further 5 years.GlobeNewsWire • 02/22/24
AstraZeneca rallies as results show Tagrisso slows lung cancer progressionProactive Investors • 02/19/24
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung CancerBusiness Wire • 02/19/24
This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less riskMarket Watch • 02/12/24
Got $5,000? These 3 Stocks Are Near Their 52-Week Lows and Are Underrated BuysThe Motley Fool • 02/10/24